These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 15125388

  • 21. [Laboratory and morphologic parameters in patients with lupus nephritis].
    Rasković S, Bogić M, Perić-Popadić A, Stefanović L, Arandjelović S, Jovicić Z, Bolpacić J, Tomić-Spirić V.
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.
    Petri M, Jones RJ, Brodsky RA.
    Arthritis Rheum; 2003 Jan; 48(1):166-73. PubMed ID: 12528116
    [Abstract] [Full Text] [Related]

  • 26. Lupus nephritis in children.
    Hafeez F, Tarar AM, Saleem R.
    J Coll Physicians Surg Pak; 2008 Jan; 18(1):17-21. PubMed ID: 18452662
    [Abstract] [Full Text] [Related]

  • 27. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
    Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.
    Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
    [Abstract] [Full Text] [Related]

  • 28. [Therapy of lupus nephritis with standard therapeutic protocols and cyclosporine].
    Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S.
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():13-8. PubMed ID: 12583308
    [Abstract] [Full Text] [Related]

  • 29. Childhood-onset lupus nephritis: a single-center experience of pulse intravenous cyclophosphamide therapy.
    Barbano G, Gusmano R, Damasio B, Alpigiani MG, Buoncompagni A, Gattorno M, Perfumo F.
    J Nephrol; 2002 Aug; 15(2):123-9. PubMed ID: 12018627
    [Abstract] [Full Text] [Related]

  • 30. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C, Bajema IM, Florquin S, Steenbergen EJ, Peutz-Kootstra CJ, Goldschmeding R, Bijl M, Hagen EC, Van Houwelingen HC, Derksen RH, Berden JH, Dutch Working Party on Systemic Lupus Erythematosus.
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [Abstract] [Full Text] [Related]

  • 31. The prognosis and pathogenesis of severe lupus glomerulonephritis.
    Schwartz MM, Korbet SM, Lewis EJ, Collaborative Study Group.
    Nephrol Dial Transplant; 2008 Apr; 23(4):1298-306. PubMed ID: 18045825
    [Abstract] [Full Text] [Related]

  • 32. Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis.
    Gunnarsson I, Sundelin B, Jónsdóttir T, Jacobson SH, Henriksson EW, van Vollenhoven RF.
    Arthritis Rheum; 2007 Apr; 56(4):1263-72. PubMed ID: 17393458
    [Abstract] [Full Text] [Related]

  • 33. Lupus nephritis.
    Sauter M, Anders HJ.
    Minerva Med; 2007 Dec; 98(6):749-58. PubMed ID: 18299686
    [Abstract] [Full Text] [Related]

  • 34. Intravenous cyclophosphamide in lupus nephritis.
    Leondike MR, Shattuck MA.
    J Intraven Nurs; 1993 Dec; 16(1):23-7. PubMed ID: 8437043
    [Abstract] [Full Text] [Related]

  • 35. Hepatocyte growth factor and transforming growth factor beta1 ratio at baseline can predict early response to cyclophosphamide in systemic lupus erythematosus nephritis.
    Capuano A, Costanzi S, Peluso G, Zannoni G, Vellone VG, Gremese E, Zoli A, Scott C, Beltrami CA, Romano G, Ferraccioli G.
    Arthritis Rheum; 2006 Nov; 54(11):3633-9. PubMed ID: 17075808
    [Abstract] [Full Text] [Related]

  • 36. [Treatment of acute systemic lupus erythematosus with intravenous infusions of cyclophosphamide. Value and limitations].
    De Bandt M, Goycochea MV, Meyer O, Delahousse M, Palazzo E, M'Bappé P, Kahn MF.
    Ann Med Interne (Paris); 1994 Nov; 145(2):75-87. PubMed ID: 8024184
    [Abstract] [Full Text] [Related]

  • 37. Synchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis.
    Danieli MG, Palmieri C, Salvi A, Refe MC, Strusi AS, Danieli G.
    J Clin Apher; 2002 Nov; 17(2):72-7. PubMed ID: 12210709
    [Abstract] [Full Text] [Related]

  • 38. [Survival of patients with diffuse glomerulonephritis in disseminated lupus erythematosus treated with a combination of anticoagulants, corticosteroids and immunosuppressants].
    Belovezhdov N, Dimitrova V.
    Vutr Boles; 1987 Nov; 26(1):21-7. PubMed ID: 3590722
    [Abstract] [Full Text] [Related]

  • 39. Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis.
    Illei GG, Yarboro CH, Kuroiwa T, Schlimgen R, Austin HA, Tisdale JF, Chitkara P, Fleisher T, Klippel JH, Balow JE, Boumpas DT.
    Rheumatology (Oxford); 2007 Jun; 46(6):952-6. PubMed ID: 17317716
    [Abstract] [Full Text] [Related]

  • 40. Retrospective analysis of patients with lupus nephritis: data from a large clinical immunological center in Hungary.
    Brugos B, Kiss E, Szodoray P, Szegedi G, Zeher M.
    Scand J Immunol; 2006 Oct; 64(4):433-7. PubMed ID: 16970686
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.